Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

Condition:   OSA Interventions:   Drug: Atomoxetine 80 mg plus Oxybutynin 5 mg;   Drug: Atomoxetine 80 MG;   Drug: Placebo Sponsor:   Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials